These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7477573)

  • 1. [Clinical study of adjuvant systemic chemotherapy in breast cancer in The Netherlands assumes a greater number of patients than is available].
    Gaasbeek Janzen HM; Eliel M
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2111. PubMed ID: 7477573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies of adjuvant systemic chemotherapy in breast cancer in The Netherlands assumes a greater number of patients than is available].
    Blijham GH
    Ned Tijdschr Geneeskd; 1995 Aug; 139(31):1599-602. PubMed ID: 7675145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of post-chemotherapy tamoxifen in early breast cancer.
    Tolcher AW
    Oncology (Williston Park); 1994 Nov; 8(11):39-43; discussion 47-9. PubMed ID: 7826838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective: breast cancer adjuvant therapy after two decades. Clinical progress but a "partial circle" in investigation.
    Chlebowski RT
    Am J Clin Oncol; 1993 Dec; 16(6):532-5. PubMed ID: 8256773
    [No Abstract]   [Full Text] [Related]  

  • 5. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of a study on fatigue in breast cancer patients receiving adjuvant chemotherapy: the first four days after treatment are the worst].
    de Jong N; Kester AD; Schouten HC; Abu-Saad HH; Courtens AM
    Pflege Z; 2007 Nov; 60(11):620-5. PubMed ID: 18062627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New criteria for selecting elderly patients for breast cancer adjuvant treatment studies.
    Dellapasqua S; Colleoni M; Castiglione M; Goldhirsch A
    Oncologist; 2007 Aug; 12(8):952-9. PubMed ID: 17766654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in adjuvant chemotherapy for breast cancer: the role of taxanes.
    Kaklamani VG; Gradishar WJ
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S107-18. PubMed ID: 19795584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of adjuvant chemotherapy in stage II breast cancer in the last 25 years--a brief review].
    Sulkes A
    Harefuah; 2002 Apr; 141(4):374-8, 408. PubMed ID: 12017895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy and hormonal therapy for older adults with breast cancer.
    Hurria A
    Semin Oncol; 2008 Dec; 35(6):618-24. PubMed ID: 19027465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant chemotherapy use and outcomes in older women with breast cancer: what have we learned?
    Silliman RA; Ganz PA
    J Clin Oncol; 2006 Jun; 24(18):2697-9. PubMed ID: 16782908
    [No Abstract]   [Full Text] [Related]  

  • 13. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
    Biganzoli L; Aapro M
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of adjuvant chemotherapy of breast cancer from Bonadonna to the taxanes].
    Nagykálnai T
    Magy Onkol; 2002; 46(4):307-13. PubMed ID: 12563352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Breast carcinoma--adjuvant chemo- and hormone therapy].
    Fey MF
    Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials referral resource. Adjuvant therapy in breast cancer.
    Cheson BD; Phillips PH; Abrams J
    Oncology (Williston Park); 1994 Nov; 8(11):55, 60, 65. PubMed ID: 7826839
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concerning: F. Cavalli: Adriamycin/cyclophosphamide: current standard in adjuvant therapy of breast carcinoma? (Schweiz Med. Wochenschr 1994; 124:1882-1884)].
    Sauter C
    Schweiz Med Wochenschr; 1995 Jan; 125(1-2):47. PubMed ID: 7839111
    [No Abstract]   [Full Text] [Related]  

  • 19. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
    Wynendaele W; van Oosterom AT
    Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan].
    Ikeda T
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():370-6. PubMed ID: 7986117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.